News

Urgent fat jabs warning over ‘potentially catastrophic’ side effect with ‘frightening’ impact on your bones
FAT JABS have taken the nation’s waistline by storm – trimming inches and helping thousands shed weight, and fast. But it ...
The Pharma Letter5h
Zuellig Pharma launches Lilly’s Mounjaro in Thailand
Thai healthcare solutions company Zuellig Pharma has announced that Mounjaro (tirzepatide), Eli Lilly’s (NYSE: LLY) ...
Ophthalmology Advisor6h
FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs
A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.
Psychiatry Advisor15h
How GLP-1s Could Help People Sleep Better — Beyond Weight Loss
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
NewsNation on MSN16h
Wegovy vs. Zepbound: Study reveals which is better for weight loss
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy.